Case Report: Pathological Complete Response to Neoadjuvant Alectinib in a Patient With Resectable ALK-Positive Non-Small Cell Lung Cancer

Overview of attention for article published in Frontiers in Pharmacology, July 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,881 followers.

New Research: Case Report: Pathological Complete Response to Neoadjuvant Alectinib in a Patient With Resectable ALK-Positive Non-Small Cell Lung Cancer https://t.co/D3RHPWuRwa #pharmacology

06 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.